CD74 is a regulator of hematopoietic stem cell maintenance

被引:17
|
作者
Becker-Herman, Shirly [1 ]
Rozenberg, Milena [1 ]
Hillel-Karniel, Carmit [1 ]
Gil-Yarom, Naama [1 ]
Kramer, Mattias [1 ]
Barak, Avital [1 ]
Sever, Lital [1 ]
David, Keren [1 ]
Radomir, Lihi [1 ]
Lewinsky, Hadas [1 ]
Levi, Michal [1 ]
Friedlander, Gilgi [2 ,3 ]
Bucala, Richard [4 ]
Peled, Amnon [5 ]
Shachar, Idit [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel
[2] Weizmann Inst Sci, Ilana & Pascal Mantoux Inst Bioinformat, Rehovot, Israel
[3] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Rehovot, Israel
[4] Yale Sch Med, Internal Med, New Haven, CT USA
[5] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel
关键词
D O I
10.1371/journal.pbio.3001121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic stem and progenitor cells (HSPCs) are a small population of undifferentiated cells that have the capacity for self-renewal and differentiate into all blood cell lineages. These cells are the most useful cells for clinical transplantations and for regenerative medicine. So far, it has not been possible to expand adult hematopoietic stem cells (HSCs) without losing their self-renewal properties. CD74 is a cell surface receptor for the cytokine macrophage migration inhibitory factor (MIF), and its mRNA is known to be expressed in HSCs. Here, we demonstrate that mice lacking CD74 exhibit an accumulation of HSCs in the bone marrow (BM) due to their increased potential to repopulate and compete for BM niches. Our results suggest that CD74 regulates the maintenance of the HSCs and CD18 expression. Its absence leads to induced survival of these cells and accumulation of quiescent and proliferating cells. Furthermore, in in vitro experiments, blocking of CD74 elevated the numbers of HSPCs. Thus, we suggest that blocking CD74 could lead to improved clinical insight into BM transplant protocols, enabling improved engraftment.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Heterodimerization of CD74 and CD20 by two hexavalent, bispecific, anti-CD20/CD74 antibodies leads to potent cytotoxicity in mantle cell lymphoma
    Gupta, Pankaj
    Rossi, Edmund A.
    Goldenberg, David M.
    Chang, Chien-Hsing
    CANCER RESEARCH, 2011, 71
  • [22] Potential protumor function of CD74 in clear cell renal cell carcinoma
    Ezaki, Ayano
    Yano, Hiromu
    Pan, Cheng
    Fujiwara, Yukio
    Anami, Toshiki
    Ibe, Yuki
    Motoshima, Takanobu
    Yatsuda, Junji
    Esumi, Shigeyuki
    Miura, Yuji
    Kamba, Tomomi
    Komohara, Yoshihiro
    HUMAN CELL, 2024, 37 (05) : 1535 - 1543
  • [23] Expression of CD74 in primary cutaneous T-Cell Lymphomas
    Lodin, T.
    Baltaci, M.
    Mathas, S.
    Hummel, M.
    Assaf, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 49 - 50
  • [24] SFRP1 IS AN EXTRINSIC REGULATOR OF CELL CYCLING AND MAINTENANCE OF HEMATOPOIETIC STEM CELLS
    Oostendorp, R. A. J.
    Istvanffy, R.
    Renstroem, J.
    Kroeger, M.
    Shimono, A.
    Peschel, C.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S2 - S2
  • [25] CD74 interacts with APP and suppresses the production of Aβ
    Matsuda, Shuji
    Matsuda, Yukiko
    D'Adamio, Luciano
    MOLECULAR NEURODEGENERATION, 2009, 4
  • [26] CD74: a prospective marker for reactive microglia?
    Potru, Phani Sankar
    Spittau, Bjoern
    NEURAL REGENERATION RESEARCH, 2023, 18 (12) : 2673 - 2674
  • [27] CD74:a prospective marker for reactive microglia?
    Phani Sankar Potru
    Bj?rn Spittau
    Neural Regeneration Research, 2023, 18 (12) : 2673 - 2674
  • [28] CD74 interacts with APP and suppresses the production of Aβ
    Shuji Matsuda
    Yukiko Matsuda
    Luciano D'Adamio
    Molecular Neurodegeneration, 4
  • [29] Disrupting T cell memory to promote stress resilience: A role for CD74?
    Vecchiarelli, Haley A.
    Tremblay, Marie-Eve
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 114 : 240 - 241
  • [30] CD74: A new candidate target for the immunotherapy of B-Cell neoplasms
    Stein, Rhona
    Mattes, M. Jules
    Cardillo, Thomas M.
    Hansen, Hans J.
    Chang, Chien-Hsing
    Burton, Jack
    Govindan, Serengulam
    Goldenberg, David M.
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5556S - 5563S